348,025 Shares in Kenvue Inc. $KVUE Purchased by Oak Family Advisors LLC

Oak Family Advisors LLC bought a new position in shares of Kenvue Inc. (NYSE:KVUE) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 348,025 shares of the company’s stock, valued at approximately $6,003,000. Kenvue comprises approximately 1.6% of Oak Family Advisors LLC’s portfolio, making the stock its 19th largest position.

Several other hedge funds have also recently bought and sold shares of KVUE. Sumitomo Mitsui DS Asset Management Company Ltd raised its position in Kenvue by 27.1% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 310,686 shares of the company’s stock valued at $5,042,000 after purchasing an additional 66,192 shares in the last quarter. Allstate Corp acquired a new stake in Kenvue in the 3rd quarter valued at about $1,152,000. Aberdeen Group plc raised its position in Kenvue by 84.1% in the 3rd quarter. Aberdeen Group plc now owns 1,411,380 shares of the company’s stock valued at $22,914,000 after purchasing an additional 644,930 shares in the last quarter. Oak Thistle LLC acquired a new stake in Kenvue in the 4th quarter valued at about $1,563,000. Finally, Eubel Brady & Suttman Asset Management Inc. raised its position in Kenvue by 39.7% in the 3rd quarter. Eubel Brady & Suttman Asset Management Inc. now owns 1,371,886 shares of the company’s stock valued at $22,266,000 after purchasing an additional 389,704 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Kenvue Price Performance

Shares of NYSE KVUE opened at $17.74 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The firm has a market capitalization of $34.06 billion, a PE ratio of 23.04, a price-to-earnings-growth ratio of 4.01 and a beta of 0.55. The stock’s 50-day simple moving average is $17.65 and its 200-day simple moving average is $17.24.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same quarter last year, the company earned $0.24 EPS. The business’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, equities research analysts forecast that Kenvue Inc. will post 1.1 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th will be given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend is Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is 107.79%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on KVUE shares. Canaccord Genuity Group increased their price target on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Wednesday, February 18th. Argus raised Kenvue to a “hold” rating in a research report on Friday, March 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research report on Wednesday, April 8th. Barclays reduced their price target on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. Finally, Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the company from $23.00 to $18.00 in a research report on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.33.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.